UnitedHealth Group stock plunged on rising medical costs, leadership shifts, and a DOJ probe, plus 2025 guidance withdrawal.

These initiatives are integral to market access, as companies recognise that their societal impact can significantly influence their ability to bring new therapies to patients. As healthcare ...

While the shadow of the pandemic recedes, its effects linger in the form of a market correction and an evolving healthcare landscape. This, coupled with looming patent expirations, the impact of ...